# VyrarX reviews (2026): GLP-1 telehealth sellers | This GLP Both figures are entry-tier, and maintenance-dose pricing is not disclosed. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/vyrarx Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Entry tier, no ceiling # VyrarX review Both figures are entry-tier, and maintenance-dose pricing is not disclosed. ## The verdict VyrarX publishes from $179 a month for compounded semaglutide and from $329 for tirzepatide. Both are entry-tier figures. Maintenance-dose pricing is not publicly disclosed. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection States 47 From From $179/mo Prescription Required Compounded Yes — not FDA-approved VyrarX sells both molecules by injection. Free shipping and provider messaging are included. Two entry figures are published. 1. ## Who writes the prescription, and what do they see? One-to-one provider messaging is named as included. No clinician is described. The intake is not documented. The inclusion of direct messaging is a real disclosure. The omission of maintenance pricing is a bigger one, and the pages state it rather than hiding it. 2. ## What happens when the dose goes up? Entry-tier is the seller's own word. Maintenance-dose pricing is not disclosed, so the figure a reader will pay at a therapeutic dose is unknown. 3. ## What the price includes Six months at $179 is $1,074 at the entry tier, and tirzepatide at $329 is $1,974. Both totals apply only while a reader stays at the entry dose. Ask what maintenance costs before ordering. 4. ## What it claims, and what it cites Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named. ## Where it holds up, and where it does not - Strength: One-to-one provider messaging included - Strength: Free shipping on both lines - Strength: The entry-tier limit is stated - Limitation: Maintenance pricing is not disclosed - Limitation: Both figures also use from wording - Limitation: No milligram dose published - Limitation: No state coverage list is recorded ## What the evidence says about this kind of treatment The assessment above is about VyrarX. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who will ask what maintenance costs before starting. Wrong for A reader budgeting a year from the entry figure. ## The evidence behind what VyrarX prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How VyrarX compares | Seller | Who it suits | Go | | --- | --- | --- | | Vitalex Health | Readers wanting tirzepatide who will confirm the figure applies to it | | | Wellspring Longevity Clinic | Readers who want a custom blend and will ask what theirs costs | | | WeightRx | Readers wanting tirzepatide who will confirm the figure before ordering | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [TelePeptide](https://thisglp.com/reviews/telepeptide) [TeleSlim Clinic](https://thisglp.com/reviews/teleslim-clinic) [TeleZen MD](https://thisglp.com/reviews/telezen-md) [Tell Her Doc](https://thisglp.com/reviews/tellherdoc) [Telos Rx](https://thisglp.com/reviews/telos-rx) [The Aesthetic Concierge](https://thisglp.com/reviews/the-aesthetic-concierge) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked What does a maintenance dose cost? Not disclosed. Both published figures are entry-tier. What is included? Free shipping and one-to-one provider messaging. Is $179 a rate? It uses from wording at the entry tier, so it is a floor twice over. Is VyrarX expensive compared with other GLP-1 telehealth sellers? VyrarX publishes a starting figure of $179/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts VyrarX below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).